ATE390125T1 - Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe - Google Patents

Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe

Info

Publication number
ATE390125T1
ATE390125T1 AT04757846T AT04757846T ATE390125T1 AT E390125 T1 ATE390125 T1 AT E390125T1 AT 04757846 T AT04757846 T AT 04757846T AT 04757846 T AT04757846 T AT 04757846T AT E390125 T1 ATE390125 T1 AT E390125T1
Authority
AT
Austria
Prior art keywords
hydro
fluoro
formulation
inhaler
propellants
Prior art date
Application number
AT04757846T
Other languages
English (en)
Inventor
George Destefano
Linda Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE390125T1 publication Critical patent/ATE390125T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT04757846T 2003-03-20 2004-03-19 Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe ATE390125T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20

Publications (1)

Publication Number Publication Date
ATE390125T1 true ATE390125T1 (de) 2008-04-15

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04757846T ATE390125T1 (de) 2003-03-20 2004-03-19 Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe

Country Status (28)

Country Link
US (1) US7914770B2 (de)
EP (1) EP1608336B1 (de)
JP (1) JP4708332B2 (de)
KR (1) KR101113003B1 (de)
CN (1) CN1761455A (de)
AT (1) ATE390125T1 (de)
AU (1) AU2004224367B2 (de)
BR (1) BRPI0408547A (de)
CA (1) CA2519523C (de)
CO (1) CO5640070A2 (de)
CY (1) CY1108137T1 (de)
DE (1) DE602004012718T2 (de)
DK (1) DK1608336T3 (de)
EA (1) EA009087B1 (de)
EC (1) ECSP056029A (de)
ES (1) ES2304616T3 (de)
HR (1) HRP20050822B1 (de)
ME (1) ME00420B (de)
MX (1) MXPA05009920A (de)
NO (1) NO336457B1 (de)
NZ (1) NZ542957A (de)
PL (1) PL1608336T3 (de)
PT (1) PT1608336E (de)
RS (1) RS51663B (de)
SI (1) SI1608336T1 (de)
UA (1) UA89751C2 (de)
WO (1) WO2004084858A2 (de)
ZA (1) ZA200506463B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
BRPI0512878A (pt) 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
US20090048296A1 (en) * 2007-08-17 2009-02-19 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
EP2585151B1 (de) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Vernebler
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
EP2835146B1 (de) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Zerstäuber
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék
CA2948071C (en) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Container, nebulizer and use
WO2016164508A1 (en) * 2015-04-10 2016-10-13 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2021216779A1 (en) * 2020-04-21 2021-10-28 Amphastar Pharmaceuticals, Inc. Anti-viral pharmaceutical formulations administered via devices for lung targeted delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
ES2129117T3 (es) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
CA2161632C (en) 1993-04-30 1999-08-10 Todd D. Alband Seal configuration for aerosol canister
EP0708805B9 (de) 1993-07-15 2012-03-21 Minnesota Mining And Manufacturing Company Dichtungen für eine vorrichtung zum abgeben eines aerosols
CA2218179A1 (en) * 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for beclomethasone dipropionate
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (de) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhalator mit Mitteln um chemische Stabilität der darin enthaltenen medizinischen Aerosollösung zu verbessern
CA2452140C (en) 2001-06-26 2010-12-14 Norton Healthcare, Ltd. An improved aerosol actuator

Also Published As

Publication number Publication date
AU2004224367B2 (en) 2009-10-08
MXPA05009920A (es) 2005-11-04
WO2004084858A3 (en) 2004-11-04
NO336457B1 (no) 2015-08-31
WO2004084858A2 (en) 2004-10-07
JP2006520797A (ja) 2006-09-14
NZ542957A (en) 2008-09-26
DK1608336T3 (da) 2008-06-02
NO20054839L (no) 2005-10-19
BRPI0408547A (pt) 2006-03-07
EA200501363A1 (ru) 2006-04-28
KR20050111382A (ko) 2005-11-24
UA89751C2 (ru) 2010-03-10
CA2519523A1 (en) 2004-10-07
PT1608336E (pt) 2008-04-21
US7914770B2 (en) 2011-03-29
DE602004012718T2 (de) 2009-05-07
PL1608336T3 (pl) 2008-09-30
SI1608336T1 (sl) 2008-08-31
EP1608336A2 (de) 2005-12-28
ECSP056029A (es) 2006-01-27
CY1108137T1 (el) 2014-02-12
EP1608336B1 (de) 2008-03-26
CO5640070A2 (es) 2006-05-31
HRP20050822A2 (en) 2006-10-31
ES2304616T3 (es) 2008-10-16
EA009087B1 (ru) 2007-10-26
DE602004012718D1 (de) 2008-05-08
AU2004224367A1 (en) 2004-10-07
CA2519523C (en) 2012-03-13
JP4708332B2 (ja) 2011-06-22
CN1761455A (zh) 2006-04-19
RS20050705A (sr) 2008-04-04
RS51663B (sr) 2011-10-31
ZA200506463B (en) 2006-04-26
ME00420B (me) 2011-12-20
US20040184994A1 (en) 2004-09-23
HRP20050822B1 (hr) 2013-09-30
KR101113003B1 (ko) 2012-02-24

Similar Documents

Publication Publication Date Title
DE602004012718D1 (de) Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe
BRPI0517493A (pt) polinucleotìdeo isolado, promotor vetor de expressão, célula hospedeira e uso de um polinucleotìdeo
DE60138404D1 (de) Verbessertes system zur regulation der transgenexpression
BRPI0412310A (pt) uso de um agente controlador de reologia, agente modificador de reologia, concentrados, e, composições com reologia melhorada
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
DE50210313D1 (de) Amphotere sterole und deren verwendung
CY1105337T1 (el) Πρωτοτυπες διυδροπτepιδινονες, μεθοδος για την παραγωγη τους και η χρηση τους ως φαρμακευτικα μεσα
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
TR200702139T2 (tr) Yeni bitki tanım yapıları
DK1266011T3 (da) Svampetranskriptionsaktivator, der er anvendelig i fremgangsmåder til fremstilling af polypeptider
EA200700042A1 (ru) РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
ATE413421T1 (de) Beschichtungszusammensetzung basierend auf thiol- nco-härtung
MXPA05011962A (es) Oxiarenos substituidos.
DE502005006425D1 (de) N-ethylpyrrolidon in der herstellung von polyurethandispersionen
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
EA200401621A1 (ru) Модуляторы сск-1 рецепторов
ATE380208T1 (de) Isocyanatfreie schäumbare mischungen
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
ATE549351T1 (de) Chimärer peptidantagonist für gpcr135 oder gpcr142
DK1305406T3 (da) Modulering af gamma-sekretaseaktivitet
ATE273394T1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
DE60328621D1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
DE50109166D1 (de) Verfahren zur verbesserung der transfektionseffizienz
CY1105561T1 (el) Προαγωγεας για τον λειτουργικο χαρακτηρισμο υποδοχεων συζευγμενων με την πρωτεϊνη g στον ζυμομυκητα saccharomyces cerevisiae

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1608336

Country of ref document: EP